Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP905625.RA7yFerBetSjVF98aVSerLhc55miSTU5uA9xYtbJ-FlhQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP905625.RA7yFerBetSjVF98aVSerLhc55miSTU5uA9xYtbJ-FlhQ130_assertion type Assertion NP905625.RA7yFerBetSjVF98aVSerLhc55miSTU5uA9xYtbJ-FlhQ130_head.
- NP905625.RA7yFerBetSjVF98aVSerLhc55miSTU5uA9xYtbJ-FlhQ130_assertion description "[Moreover, when XPD mutations prevent interaction with the p44 subunit of TFIIH, transactivation directed by certain nuclear receptors is inhibited, regardless of TTD versus XP phenotype, thus explaining the overlapping symptoms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP905625.RA7yFerBetSjVF98aVSerLhc55miSTU5uA9xYtbJ-FlhQ130_provenance.
- NP905625.RA7yFerBetSjVF98aVSerLhc55miSTU5uA9xYtbJ-FlhQ130_assertion evidence source_evidence_literature NP905625.RA7yFerBetSjVF98aVSerLhc55miSTU5uA9xYtbJ-FlhQ130_provenance.
- NP905625.RA7yFerBetSjVF98aVSerLhc55miSTU5uA9xYtbJ-FlhQ130_assertion SIO_000772 12820975 NP905625.RA7yFerBetSjVF98aVSerLhc55miSTU5uA9xYtbJ-FlhQ130_provenance.
- NP905625.RA7yFerBetSjVF98aVSerLhc55miSTU5uA9xYtbJ-FlhQ130_assertion wasDerivedFrom befree-20140225 NP905625.RA7yFerBetSjVF98aVSerLhc55miSTU5uA9xYtbJ-FlhQ130_provenance.
- NP905625.RA7yFerBetSjVF98aVSerLhc55miSTU5uA9xYtbJ-FlhQ130_assertion wasGeneratedBy ECO_0000203 NP905625.RA7yFerBetSjVF98aVSerLhc55miSTU5uA9xYtbJ-FlhQ130_provenance.